Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Advancing Understanding, Diagnosis and Monitoring of Thyroid Hormone Action Defects (ADAM-THAD)

NCT06307990 is registered in ClinicalTrials.gov with Istituto Auxologico Italiano as lead sponsor.

NCT NCT06307990
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06307990 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Advancing Understanding, Diagnosis and Monitoring of Thyroid Hormone Action Defects (ADAM-THAD)
Lead sponsor
Istituto Auxologico Italiano
Phase
Observational
Overall status
Recruiting
Start date
January 1, 2023
Completion date
January 31, 2026
Enrollment
150 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

resistance, thyroid hormone